MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
2.235
-0.005 (-0.22%)
At close: Jul 3, 2025, 1:00 PM
2.240
+0.005 (0.22%)
After-hours: Jul 3, 2025, 4:13 PM EDT
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $237.84 million as of July 3, 2025. Its market cap has decreased by -51.49% in one year.
Market Cap
237.84M
Enterprise Value
118.39M
1-Year Change
-51.49%
Ranking
Category
Stock Price
$2.24
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $237.84M, a decrease of -51.92%. That is a compound annual growth rate of -15.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 237.84M | -45.91% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |